Pediatric Atrial Flutter Workup
- Author: M Silvana Horenstein, MD; Chief Editor: Steven R Neish, MD, SM more...
A 12-lead to 15-lead ECG is the mainstay of atrial flutter diagnosis. Atrial flutter is a reentrant arrhythmia circuit confined to the atrial chambers. Such a circuit may be macroscopic and, therefore, amenable to mapping by techniques using standard electrophysiologic catheters or it may be microscopic and amenable to mapping only in the research laboratory using fine electrode arrays.
Depending on the drug used, patients receiving antiarrhythmic therapy may benefit from the monitoring of specific drug blood levels and electrolyte and creatinine levels or ECG monitoring of the QTc (eg, class III agents).
Electrophysiologic studies may be useful for mapping arrhythmia circuits. Consider transesophageal echocardiography in patients with associated structural or functional heart disease to ascertain the presence of intracardiac thrombi, myocardial dysfunction, or hemodynamically important residual structural defects that could predispose them to atrial flutter.
Optimize anticoagulation through monitoring of coagulation profiles in patients receiving heparin or warfarin. In patients with documented intracardiac thrombi, monitor for the presence of associated thrombophilia, as indicated.
A rapid atrial tachycardia with uniform P waves with flutter morphology and variable atrioventricular (AV) block indicates that atrial flutter or atrial ectopic tachycardia is present. See the image below.
If the onset of tachycardia has been recorded, the absence of "warm-up" of the tachycardia cycle length makes atrial flutter the most likely diagnosis. Similarly, sudden termination of the tachycardia points to atrial flutter.
If the conduction ratio is consistently 1:1, the diagnosis is more difficult. The QRS complex may be aberrantly conducted at this rate, and ventricular tachycardia must be considered in the differential diagnosis. A 1:1 conduction ratio may produce a ventricular rate of 300 beats per minute in children, in patients with the pre-excitation syndrome, in those whose AV nodes conduct rapidly, and occasionally in patients with hyperthyroidism.
With a 2:1 conduction ratio, every other flutter wave may be hidden within the QRS complex. In this case, the ECG findings often suggest a mild sinus tachycardia with first-degree AV block. Because adrenergic states that cause sinus tachycardia usually shorten rather than prolong the PR interval, the differential diagnosis of atrial flutter should be considered.
Assessment of heart rate or conduction ratio responses to vagal maneuvers or adenosine may be helpful.
According to one study, V1 was the most important ECG lead that aided diagnosis of the supraventricular tachycardia (SVT) mechanism; the study also reported that combining V1 with the inferior limb lead III increased the chances of identifying the SVT mechanism from 80% to 96%.
In patients with possible atrial flutter occurring soon after the repair of congenital heart disease, the use of temporary atrial wires is extremely helpful in diagnosis and therapy. Unipolar atrial wire recordings or bipolar recordings with a simultaneously recorded surface ECG can often be used to confirm a suspected atrial flutter with 2:1 conduction ratio by unmasking the second flutter wave.
In patients without temporary atrial wires, the use of an esophageal electrode placed behind the left atrium is also extremely helpful for diagnosis and therapy. Bipolar recordings with a simultaneously recorded surface ECG can be optimized by advancing or withdrawing the electrode until the atrial electrogram is at its maximal size.
Modern atrial or dual-chamber pacemakers can provide a unipolar or bipolar atrial electrogram by telemetry from the device.
P-wave signal averaging using a specialized ECG has demonstrated some ability to differentiate adults who are likely to develop occurrences or recurrences of atrial fibrillation. This technique has been adapted to predict the occurrence of atrial flutter following the Fontan procedure.
Electrical termination of atrial flutter and additional testing can be performed through atrial wires, esophageal electrodes, permanent pacing systems, or with an intracardiac electrophysiology study. These studies may identify whether an arrhythmia is reproducibly overdriveable, and invasive testing may help identify the specific arrhythmia circuit.
Three-dimensional electroanatomical physiologic mapping of atrial arrhythmias is helpful, especially in patients who have undergone atriotomies because of the presence of multiple, extended, and/or complex reentry circuits.
The reentrant arrhythmia circuit confined to the atrial chambers may be macroscopic and mappable using standard electrophysiologic catheters or it may be microscopic and mappable only in the research laboratory using fine electrode arrays.
Postcatheterization precautions include hemorrhage, vascular disruption (if the patient underwent concomitant balloon dilation of a stenosed vessel), pain, nausea and vomiting, and arterial or venous obstruction from thrombosis or spasm. Complications may also include tachyarrhythmias or bradyarrhythmias.
Biviano A, Garan H, Hickey K, Whang W, Dizon J, Rosenbaum M. Atrial flutter catheter ablation in adult patients with repaired tetralogy of Fallot: mechanisms and outcomes of percutaneous catheter ablation in a consecutive series. J Interv Card Electrophysiol. 2010 Aug. 28(2):125-35. [Medline].
Boriani G, Gallina M, Merlini L, et al. Clinical relevance of atrial fibrillation/flutter, stroke, pacemaker implant, and heart failure in Emery-Dreifuss muscular dystrophy: a long-term longitudinal study. Stroke. 2003 Apr. 34(4):901-8. [Medline].
Nazarian S, Wagner KR, Caffo BS, Tomaselli GF. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy. Pacing Clin Electrophysiol. 2011 Feb. 34(2):171-6. [Medline]. [Full Text].
Frost L, Hune LJ, Vestergaard P. Overweight, obesity and risk factors for atrial fibrillation or flutter--secondary publication.The cohort study Diet, Cancer and Health. Ugeskr Laeger. 2005 Sep 12. 167(37):3507-9. [Medline].
Frost L, Vestergaard P. Alcohol consumption and the risk of atrial fibrillation or flutter--secondary publication. A cohort study. Ugeskr Laeger. 2005 Aug 29. 167(35):3308-10. [Medline].
Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter--secondary publication. A population-based study. Ugeskr Laeger. 2005 Aug 29. 167(35):3305-7. [Medline].
Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005 Dec 7. 105(3):315-8. [Medline].
Earing MG, Cetta F, Driscoll DJ. Long-term results of the Fontan operation for double-inlet left ventricle. Am J Cardiol. 2005 Jul 15. 96(2):291-8. [Medline].
Balaji S, Daga A, Bradley DJ, Etheridge SP, Law IH, Batra AS, et al. An international multicenter study comparing arrhythmia prevalence between the intracardiac lateral tunnel and the extracardiac conduit type of Fontan operations. J Thorac Cardiovasc Surg. 2013 Oct 27. [Medline].
Krapp M, Kohl T, Simpson JM. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003 Aug. 89(8):913-7. [Medline].
Southall DP, Johnson AM, Shinebourne EA, Johnston PG, Vulliamy DG. Frequency and outcome of disorders of cardiac rhythm and conduction in a population of newborn infants. Pediatrics. 1981 Jul. 68(1):58-66. [Medline].
Silversides CK, Harris L, Haberer K. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol. 2006 Apr 15. 97(8):1206-12. [Medline].
Liberman L, Pass RH, Starc TJ. Optimal surface electrocardiogram lead for identification of the mechanism of supraventricular tachycardia in children. Pediatr Emerg Care. 2008 Jan. 24(1):28-30. [Medline].
Liberman L, Hordof AJ, Altmann K, Pass RH. Low energy biphasic waveform cardioversion of atrial arrhythmias in pediatric patients and young adults. Pacing Clin Electrophysiol. 2006 Dec. 29(12):1383-6. [Medline].
Stulak JM, Dearani JA, Puga FJ. Right-sided Maze procedure for atrial tachyarrhythmias in congenital heart disease. Ann Thorac Surg. 2006 May. 81(5):1780-4; discussion 1784-5. [Medline].
Oudijk MA, Ruskamp JM, Ververs FF, et al. Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol. 2003 Aug 20. 42(4):765-70. [Medline].
Rebelo M, Macedo AJ, Nogueira G, Trigo C, Kaku S. Sotalol in the treatment of fetal tachyarrhythmia. Rev Port Cardiol. 2006 May. 25(5):477-81. [Medline].